Hyve Group Plc
ITEPF
Other OTC1.51
USD
-0.12
- -
Hyve Group Plc
ITEPF
(Other OTC)
Recent
price
1.51
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Hyve Group Limited organizes international exhibitions, conferences, and related events across multiple industries including technology, healthcare, retail, education, commodities, engineering, manufacturing, and fintech; its core offerings encompass in-person trade shows, digital and omnichannel meetings programs, thought leadership content from industry speakers, matchmaking services facilitating over 190,000 one-on-one meetings annually, and year-round engagement solutions such as advisory-led accelerators, curated dinners, research insights, and community platforms. The company delivers transformational experiences through flagship events like Shoptalk Fall, HLTH USA (its largest revenue generator), ViVE, POSSIBLE, Bett, CWIEME, and Spring Fair, targeting business professionals, innovators, and industry ecosystems seeking networking, innovation, and commercial opportunities. Founded in 1991 as International Trade Exhibitions (originally incorporated in 1985) and headquartered at 2 Kingdom Street in London, United Kingdom, Hyve operates globally with over 650 employees across 10 offices, serving markets in the United Kingdom, United States, Asia, Eastern and Southern Europe, and other regions. In recent developments, Hyve achieved 17% organic revenue growth and 60% total proforma growth to $316 million in 2024, driven by the successful launch of Shoptalk Fall, expansion of meetings programs, and strategic acquisitions including HLTH and POSSIBLE in 2024 (expanding into high-growth healthcare and marketing sectors), 121 Group and Fintech Meetup previously for omnichannel diversification, and most recently HGAN in 2025 to enhance year-round healthcare advisory services with cross-sector potential. These moves form part of the GO27 three-year growth and optimization plan launched in 2024, backed by shareholders Providence Equity Partners (which acquired the company in 2023 at a £481 million valuation, taking it private) and Searchlight Capital, involving leadership enhancements such as a Chief Operating Officer and adoption of Objectives and Key Results methodology for operational excellence. The company continues to prioritize innovation in digitization, sustainability initiatives like community investments in carbon-negative projects, and customer-centric metrics including a +46 Net Promoter Score across major events.